- News
07/03/2025
One more time, Labiotech speaks about TransCure bioServices!
Find out more about how TransCure improves immuno-oncology research with its humanized mouse model.
“The main challenge that researchers face in preclinical #immunooncology research is to have human #tumor cells in an environment that mimics the natural habitat, because they interact with other cells in the body” 🐁 https://t.co/AYM6jWeYfc #biotech #CRO @_TransCure pic.twitter.com/AF39BKOeGl
— Labiotech.eu (@Labiotech_eu) 7 février 2019
Research on #immunotherapies dates back over a century and our knowledge of the human immune system has steadily increased. Now, we can use full human immune system mouse models to determine how #immunooncology drugs work 🐁 https://t.co/AYM6jWeYfc #biotech #CRO @_TransCure pic.twitter.com/tighokKZyA
— Labiotech.eu (@Labiotech_eu) 6 février 2019
Full human immune system mouse models have a fully functional set of human immune cells which enable researchers to study the interaction of the human immune system with #tumor cells and #immunotherapies 🐁 https://t.co/AYM6jWeYfc #biotech #CRO #oncology @_TransCure pic.twitter.com/oLgFSFIh1L
— Labiotech.eu (@Labiotech_eu) 6 février 2019